Overview
Leishmania (Kala Azar) Antibody IgG is a serological test used to detect IgG antibodies produced against Leishmania species, mainly Leishmania donovani, the causative agent of visceral leishmaniasis. Kala-azar is a zoonotic protozoal infection and a major public health problem in endemic regions. The presence of IgG antibodies indicates exposure to the parasite and may suggest current or past infection. Detection of Leishmania IgG is especially useful in the diagnosis of visceral leishmaniasis and supports clinical and epidemiological assessment.
Symptoms
Patients with visceral leishmaniasis commonly present with prolonged fever, weight loss, weakness, and loss of appetite. Hepatosplenomegaly, particularly massive splenomegaly, is a characteristic feature. Anemia, leukopenia, and thrombocytopenia may lead to fatigue, recurrent infections, and bleeding tendencies. In some cases, skin manifestations may appear after treatment as post–kala-azar dermal leishmaniasis. Cutaneous forms may show localized or widespread skin lesions.
Causes
Leishmania IgG antibodies are produced when the immune system responds to infection transmitted through the bite of infected female sandflies. After entry into the host, the parasite infects macrophages and triggers antibody production. The test detects circulating IgG antibodies using methods such as ELISA, IFAT, rK39-based assays, and other serological techniques. While IgG detection is strongly associated with visceral leishmaniasis, low levels may also be seen in some cases of cutaneous leishmaniasis.
Risk Factors
Risk factors for Leishmania IgG positivity include residence in or travel to endemic areas, poor housing conditions, malnutrition, and exposure to sandflies. Children, immunocompromised individuals, and people living in areas with high vector density are at increased risk. Close contact with endemic environments and lack of vector control measures further increase susceptibility. Cross-reactivity with other infections such as malaria or tuberculosis may influence results.
Prevention
Prevention of leishmaniasis focuses on reducing sandfly exposure through vector control, use of insecticide-treated nets, protective clothing, and environmental sanitation. Early diagnosis using serological tests like Leishmania IgG helps in timely treatment and prevention of severe complications. Public health surveillance, screening in endemic regions, and prompt management of confirmed cases play an important role in disease control and reduction of transmission.
